{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:12:38Z","timestamp":1755796358492,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR062732"],"award-info":[{"award-number":["R21AR062732"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.nano.2025.102847","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:52:40Z","timestamp":1753116760000},"page":"102847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antioxidative fullerol prevents bone loss due to its anti-osteoclastogenic and pro-osteogenic activities"],"prefix":"10.1016","volume":"68","author":[{"given":"Xinlin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changle","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Dighe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanjun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nano.2025.102847_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7861\/clinmedicine.14-2-187","article-title":"Osteoporosis and fracture risk in older people","volume":"14","author":"Coughlan","year":"2014","journal-title":"Clin Med Lond Engl"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"10.1016\/j.nano.2025.102847_bb0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"issue":"6937","key":"10.1016\/j.nano.2025.102847_bb0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.nano.2025.102847_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00223-010-9393-9","article-title":"Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures","volume":"87","author":"Baek","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.nano.2025.102847_bb0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0006-291X(05)80311-0","article-title":"Stimulation of osteoclastic bone resorption by hydrogen peroxide","volume":"183","author":"Bax","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.nano.2025.102847_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","article-title":"A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation","volume":"106","author":"Lee","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.nano.2025.102847_bb0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.nano.2025.102847_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.778078","article-title":"Macrophage-osteoclast associations: origin, polarization, and subgroups","volume":"12","author":"Sun","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.nano.2025.102847_bb0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstr\u00f6m","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"14","key":"10.1016\/j.nano.2025.102847_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143576","article-title":"Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases","volume":"20","author":"Agidigbi","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2009.05377.x","article-title":"Role of mitochondrial reactive oxygen species in osteoclast differentiation","volume":"1192","author":"Srinivasan","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.nano.2025.102847_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20230034","article-title":"Electrospun fiber-based immune engineering in regenerative medicine","volume":"3","author":"Xu","year":"2024","journal-title":"Smart Med"},{"issue":"4","key":"10.1016\/j.nano.2025.102847_bb0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.nano.2025.102847_bb0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"issue":"6","key":"10.1016\/j.nano.2025.102847_bb0085","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4049\/jimmunol.1402211","article-title":"FOXO1 mediates RANKL-induced osteoclast formation and activity","volume":"194","author":"Wang","year":"2015","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.nano.2025.102847_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"12","key":"10.1016\/j.nano.2025.102847_bb0095","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3390\/antiox12122094","article-title":"Nrf2 mitigates RANKL and M-CSF induced osteoclast differentiation via ROS-dependent mechanisms","volume":"12","author":"Yang","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"32","key":"10.1016\/j.nano.2025.102847_bb0100","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1074\/jbc.M113.478545","article-title":"The Keap1\/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling","volume":"288","author":"Kanzaki","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2025.102847_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/726590","article-title":"Effects of Nrf2 deficiency on bone microarchitecture in an experimental model of osteoporosis","volume":"2014","author":"Ib\u00e1\u00f1ez","year":"2014","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"10.1016\/j.nano.2025.102847_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12540","article-title":"Bidirectional regulation of osteogenic differentiation by the FOXO subfamily of Forkhead transcription factors in mammalian MSCs","volume":"52","author":"Chen","year":"2018","journal-title":"Cell Prolif"},{"key":"10.1016\/j.nano.2025.102847_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","article-title":"Redox regulation of FoxO transcription factors","volume":"6","author":"Klotz","year":"2015","journal-title":"Redox Biol"},{"issue":"40","key":"10.1016\/j.nano.2025.102847_bb0120","doi-asserted-by":"crossref","first-page":"31055","DOI":"10.1074\/jbc.M109.079962","article-title":"FOXO1, a novel regulator of osteoblast differentiation and Skeletogenesis","volume":"285","author":"Teixeira","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2025.102847_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijbiomac.2015.04.008","article-title":"Runx2: structure, function, and phosphorylation in osteoblast differentiation","volume":"78","author":"Vimalraj","year":"2015","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13619-024-00190-1","article-title":"Forkhead box O proteins: steering the course of stem cell fate","volume":"13","author":"Cheng","year":"2024","journal-title":"Cell Regen"},{"issue":"7","key":"10.1016\/j.nano.2025.102847_bb0135","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI42285","article-title":"The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice","volume":"120","author":"Greenblatt","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2025.102847_bb0140","doi-asserted-by":"crossref","unstructured":"Kops GJPL, Ruiter ND de, De Vries-Smits AMM, Powell DR, Bos JL, Burgering BMT. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 1999;398(6728):630\u2013634. DOI https:\/\/doi.org\/10.1038\/19328.","DOI":"10.1038\/19328"},{"issue":"2","key":"10.1016\/j.nano.2025.102847_bb0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2009.12.009","article-title":"FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice","volume":"11","author":"Ambrogini","year":"2010","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.nano.2025.102847_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00018-022-04186-5","article-title":"ROS-induced PADI2 downregulation accelerates cellular senescence via the stimulation of SASP production and NF\u03baB activation","volume":"79","author":"Kim","year":"2022","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191192","article-title":"The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors","volume":"13","author":"Ohyama","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2025.102847_bb0160","article-title":"Notopterol attenuates estrogen deficiency-induced osteoporosis via repressing RANKL signaling and reactive oxygen species","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102847_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115895","article-title":"Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation","volume":"218","author":"Feng","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nano.2025.102847_bb0170","doi-asserted-by":"crossref","unstructured":"Cui, Q, Yang, X, Ebrahimi, A, Li, J. Fullerene-biomolecule conjugates and their biomedicinal applications. Int J Nanomedicine Published online December 2013:77. https:\/\/doi.org\/10.2147\/IJN.S52829.","DOI":"10.2147\/IJN.S52829"},{"key":"10.1016\/j.nano.2025.102847_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/751913","article-title":"Fullerenols as a new therapeutic approach in nanomedicine","volume":"2013","author":"Grebowski","year":"2013","journal-title":"Biomed Res Int"},{"issue":"18","key":"10.1016\/j.nano.2025.102847_bb0180","first-page":"9665","article-title":"FULLEROL alleviates myocardial ischemia-reperfusion injury by reducing inflammation and oxidative stress in cardiomyocytes via activating the Nrf2\/HO-1 signaling pathway","volume":"24","author":"Ding","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0185","first-page":"R21","article-title":"Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs","volume":"287","author":"Chen","year":"2004","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"10.1016\/j.nano.2025.102847_bb0190","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.2147\/IJN.S60853","article-title":"Antioxidative nanofullerol prevents intervertebral disk degeneration","volume":"9","author":"Yang","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"10.1016\/j.nano.2025.102847_bb0195","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/art.22917","article-title":"Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development","volume":"56","author":"Yudoh","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.nano.2025.102847_bb0200","first-page":"639","article-title":"Medicinal applications of fullerenes","volume":"2","author":"Bakry","year":"2007","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"10.1016\/j.nano.2025.102847_bb0205","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.spinee.2013.04.004","article-title":"Fullerol nanoparticles suppress inflammatory response and adipogenesis of vertebral bone marrow stromal cells--a potential novel treatment for intervertebral disc degeneration","volume":"13","author":"Liu","year":"2013","journal-title":"Spine J"},{"key":"10.1016\/j.nano.2025.102847_bb0210","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2147\/IJN.S202466","article-title":"Antioxidative nanofullerol inhibits macrophage activation and development of osteoarthritis in rats","volume":"14","author":"Pei","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.nano.2025.102847_bb0215","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jor.22054","article-title":"Fullerol antagonizes dexamethasone-induced oxidative stress and adipogenesis while enhancing osteogenesis in a cloned bone marrow mesenchymal stem cell","volume":"30","author":"Liu","year":"2012","journal-title":"J Orthop Res"},{"key":"10.1016\/j.nano.2025.102847_bb0220","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2147\/IJN.S66785","article-title":"Antioxidative fullerol promotes osteogenesis of human adipose-derived stem cells","volume":"9","author":"Yang","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102847_bb0225","series-title":"Bone Research Protocols","first-page":"187","article-title":"RANKL-Mediated Osteoclast Formation from Murine RAW 264.7 cells","author":"Collin-Osdoby","year":"2012"},{"key":"10.1016\/j.nano.2025.102847_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/915130","article-title":"Effects of two fullerene derivatives on monocytes and macrophages","volume":"2015","author":"Pacor","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.nano.2025.102847_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15769","article-title":"Anti-inflammatory activities of two new deoxygenated N-acetyl glucosamines in lipopolysaccharide-activated mouse macrophage RAW264.7 cells","volume":"9","author":"Le","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00774-007-0797-1","article-title":"Characterization of a new experimental model of osteoporosis in rabbits","volume":"26","author":"Casta\u00f1eda","year":"2008","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"10.1016\/j.nano.2025.102847_bb0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00296-007-0452-0","article-title":"Total oxidative\/anti-oxidative status and relation to bone mineral density in osteoporosis","volume":"28","author":"Altindag","year":"2008","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.nano.2025.102847_bb0250","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2353\/ajpath.2009.090148","article-title":"High levels of tumor necrosis factor-\u03b1 contribute to accelerated loss of cartilage in diabetic fracture healing","volume":"175","author":"Alblowi","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nano.2025.102847_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156309","article-title":"Notopterol alleviates the progression of osteoarthritis: an in vitro and in vivo study","volume":"169","author":"Qu","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.nano.2025.102847_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115895","article-title":"Tussilagone inhibits osteoclastogenesis by modulating mitochondrial function and ROS production involved Nrf2 activation","volume":"218","author":"Feng","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nano.2025.102847_bb0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/IJN.S7505","article-title":"Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis","volume":"4","author":"Yudoh","year":"2009","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"10.1016\/j.nano.2025.102847_bb0270","first-page":"4801","article-title":"Fullerol-hydrogel microfluidic spheres for in situ redox regulation of stem cell fate and refractory bone healing","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.nano.2025.102847_bb0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bmt.2022.11.002","article-title":"Injectable hydrogel microspheres in cartilage repair","volume":"1","author":"Lin","year":"2023","journal-title":"Biomed Tech"},{"issue":"1","key":"10.1016\/j.nano.2025.102847_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20230034","article-title":"Electrospun fiber-based immune engineering in regenerative medicine","volume":"3","author":"Xu","year":"2024","journal-title":"Smart Med"},{"key":"10.1016\/j.nano.2025.102847_bb0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bmt.2023.06.002","article-title":"Bone regeneration and antibacterial properties of calcium-phosphorus coatings induced by gentamicin-loaded polydopamine on magnesium alloys","volume":"5","author":"Shen","year":"2024","journal-title":"Biomed Tech"},{"key":"10.1016\/j.nano.2025.102847_bb0290","unstructured":"Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry. Center for Drug Evaluation and Research; 2020. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/osteoporosis-nonclinical-evaluation-drugs-intended-treatment-guidance-industry. Accessed April 27, 2024."},{"issue":"8","key":"10.1016\/j.nano.2025.102847_bb0295","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-019-04999-4","article-title":"Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia","volume":"30","author":"Chandler","year":"2019","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.nano.2025.102847_bb0300","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:58:03Z","timestamp":1755496683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S1549963425000486"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102847","relation":{},"ISSN":["1549-9634"],"issn-type":[{"type":"print","value":"1549-9634"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antioxidative fullerol prevents bone loss due to its anti-osteoclastogenic and pro-osteogenic activities","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102847"}}